GL1X · GenesisL1 explorer

MolNFT v1 · #91336 · protein

Design and synthesis of a novel pyrrolidinyl pyrido pyrimidinone derivative as a potent inhibitor of PI3KA and mtor

4FAD · Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic…: “Design and synthesis of a novel pyrrolidinyl pyrido pyrimidinone derivative as a potent inhibitor of PI3KA…”. X-ray diffraction, 1 ligand (0TB), 12 pockets (best…

PDB
4FAD
Type
protein
Length
839 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform
EC
2.7.1.153, 2.7.11.1
UniProt
P48736
Ligands
0TB
Pockets
12 · best druggability 0.81

Structure

x-ray diffraction · 1 distinct chain · 42% helix, 17% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
APhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform (EC 2.7.1.153, 2.7.11.1)protein83942% helix, 17% strandP48736

Ligands and binding sites

  • 0TB · 2-amino-6-(5-fluoro-6-methoxypyridin-3-yl)-4-methyl-8-(pyrrolidin-1-yl)pyrido[2,3-d]pyrimidin-7(8H)-one · ligand · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

12 pockets found on a 1 Å grid, 4 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
111190.810.8274empty
24580.720.82480TB
33380.640.8040empty
41710.550.8026empty
5860.490.8220empty

Compared structures

  • 4FAD · Design and Synthesis of a Novel Pyrrolidinyl Pyrido Pyrimidi Derivative as a Potent… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.